Manu Pandey
0000-0002-5276-3806
Publication & Citation Trends
Publications
0 total
A randomized Phase II trial of ASTX727 and venetoclax with or without enasidenib for newly diagnosed older adults with IDH2 mutant Acute Myeloid Leukemia: A myelomatch substudy (MM1OA-S03)
Cited by 1
Semantic Scholar
Outpatient administration of idecabtagene vicleucel: Predictors of hospitalization and impact on survival outcomes
Cited by 0
Semantic Scholar
Real-world outcomes of CAR-T in the outpatient setting.
Cited by 0
Semantic Scholar
Results of A phase I study of peposertib in combination with MEC in patients with relapsed or refractory Acute Myeloid Leukemia
Cited by 0
Semantic Scholar
A META-ANALYSIS ON SURVIVAL AFTER LUNG TRANSPLANTATION FOR MANAGEMENT OF BRONCHIOLITIS OBLITERANS SYNDROME SECONDARY TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Cited by 0
Semantic Scholar
INTENSIVE CARE UNIT ADMISSION RATE AND OUTCOMES IN PATIENTS TREATED WITH CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY: A SYSTEMATIC REVIEW AND META-ANALYSIS
Cited by 0
Semantic Scholar
Research Topics
Cancer Immunotherapy and Biomarkers
(28)
CAR-T cell therapy research
(27)
Acute Myeloid Leukemia Research
(12)
Cancer, Stress, Anesthesia, and Immune Response
(12)
Biosimilars and Bioanalytical Methods
(7)
Affiliations
Roswell Park Comprehensive Cancer Center
SRM Institute of Science and Technology
Palo Alto University
Oklahoma City University
Oklahoma State University Oklahoma City